wersja polska  
Mediton - Publishing House
Start page  Journals  Books  Conferences  News  Mediton  Contact   
   Journals
print this
   Allergy Asthma Immunology - archive  

Allergy Asthma Immunology
     Archive
     Editorial staff
     Editorial board
     For authors
     Subscription
Otorhinolaryngology
Allergology Review



 Search in articles:
  Authority of Polish Society of Allergology




vol 11. no 4. December 2006  
 TABLE OF CONTENT

 Original articles
Safety of accelerated immunotherapy build-up schedule with Phostal in asthmatic children allergic to house dust mite
PAWEŁ MAJAK, PIOTR STELMACH, AGNIESZKA BRZOZOWSKA, IWONA STELMACH

Introduction. Accelerated immunotherapy build-up schedules offer the advantage of reduced number of office visits and cause that the procedure is better tolerated by patients and their carers.
Aim of the study. The aim of this study was to investigate the safety of accelerated immunotherapy build-up schedule with Phostal in children with asthma, allergic to house dust mite
Material and methods. In the randomized control study we compared safety of standard (14 week) and accelerated (9 week) build-up schedule of immunotherapy in 100 asthmatic children allergic to house dust mite.
Results. Ninety nine children were finally enlisted in the study (one child was excluded due to asthma exacerbation). Subcutaneus immunotherapy administered using an accelerated (n=50) and a standard (n=49) protocol was equally safe. There were no differences in local or serious adverse reactions between the study groups.
Conclusion. Accelerated (9-week) schedule used instead of the standard (14-week) build-up schedule of immunotherapy with Phostal did not increase the frequency of adverse effects in asthmatic children allergic to house dust mite.


keywords: przyspieszony schemat odczulania, dzieci, astma oskrzelowa, accelerated immunotherapy, children, bronchial asthma

pages: from 207 to 210



estimated time of download (100 kB)
broadband speed:561282565121024[kbps]
time:217432[sec]


You need to have Adobe Acrobat Reader to view the PDF file. It's free. If you don't have the Adobe Acrobat Reader plugin yet, you can get it HERE.


Start page | Journals | Books | Conferences | News | Mediton | Contact

Copyright © 1996-2020 Mediton Publishing House | All rights reserved.